Private Advisor Group’s First Trust Eurozone AlphaDEX FEUZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-17,705
Closed -$633 – 1998
2022
Q4
$633 Buy
17,705
+422
+2% +$14.2K ﹤0.01% 1331
2022
Q3
$502K Buy
17,283
+278
+2% +$9.12K 0.01% 1232
2022
Q2
$573K Sell
17,005
-778
-4% -$29.9K 0.01% 1336
2022
Q1
$734K Sell
17,783
-3,905
-18% -$169K 0.01% 1235
2021
Q4
$999K Buy
21,688
+284
+1% +$13.2K 0.01% 1122
2021
Q3
$984K Buy
21,404
+740
+4% +$35K 0.01% 1214
2021
Q2
$961K Buy
20,664
+145
+0.7% +$6.83K 0.01% 1085
2021
Q1
$912K Buy
20,519
+997
+5% +$43.2K 0.01% 1039
2020
Q4
$807K Buy
19,522
+402
+2% +$15.6K 0.01% 998
2020
Q3
$697K Buy
19,120
+1,038
+6% +$38K 0.01% 931
2020
Q2
$614K Buy
18,082
+2,776
+18% +$87.7K 0.01% 937
2020
Q1
$437K Buy
15,306
+3,055
+25% +$112K 0.01% 942
2019
Q4
$501K Buy
12,251
+2,509
+26% +$99.4K 0.01% 1045
2019
Q3
$368K Sell
9,742
-1,516
-13% -$57.1K 0.01% 1202
2019
Q2
$440K Buy
11,258
+2,412
+27% +$92.4K 0.01% 1102
2019
Q1
$334K Buy
+8,846
New +$328K 0.01% 1141

Other funds holding FEUZ

Private Advisor Group's FEUZ Position: Q1 2023 in Review

Private Advisor Group sold out of First Trust Eurozone AlphaDEX (FEUZ) in Q1 2023, closing a stake of 17,705 shares — an estimated $633 sold.

Private Advisor Group first reported a position in FEUZ in Q1 2019 and held it in 16 quarters. The position peaked at $999K in Q4 2021. 16 funds tracked by Wall St. Rank hold FEUZ as of Q1 2023.

  • Private Advisor Group reported no remaining First Trust Eurozone AlphaDEX position as of Q1 2023 after selling out during the quarter.
  • Private Advisor Group sold 17,705 First Trust Eurozone AlphaDEX shares in Q1 2023, an estimated $633.
  • Private Advisor Group first reported a position in First Trust Eurozone AlphaDEX in Q1 2019 and held it in 16 quarters.
  • Private Advisor Group's First Trust Eurozone AlphaDEX position peaked at $999K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held First Trust Eurozone AlphaDEX as of Q1 2023.

Based on Private Advisor Group's 13F filing for Q1 2023, filed 10 May 2023.